- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review.
September 4, 2020
Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma.
September 4, 2020
Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population.
September 4, 2020
Percutaneous microwave ablation of renal masses in a UK cohort.
September 3, 2020
Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence.
September 2, 2020
Neutrophil-to-mean platelet volume ratio as a new predictor for overall and cancer-specific survival in patients with localized clear cell renal cell carcinoma.
September 2, 2020
Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
September 2, 2020
Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
September 1, 2020
Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
September 1, 2020
Current evidence on screening for renal cancer.
September 1, 2020
Efficacy and safety of apatinib monotherapy in metastatic renal cell carcinoma (mRCC) patients: A single-arm observational study.
August 31, 2020
LINC00973 involves in cancer immune suppression through positive regulation of Siglec-15 in ccRCC.
August 28, 2020